The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Insanitary Conditions at Compounding Facilities



FDA is issuing this guidance to assist compounding facilities in identifying insanitary conditions so that they can implement appropriate corrective actions

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information